Download Full Text (359 KB)
- Sodium zirconium cyclosilicate (ZS-9) can acutely decrease serum potassium (K) levels after one dose and may have favorable side effects compared to sodium polystyrene sulfate (SPS).
- ZS-9 replaced oral SPS in the Hyperkalemia Order Set at St. Cloud Hospital in April 2019
- To characterize the acute potassium-lowering effects of one 10-gram dose of sodium zirconium cyclosilicate in conjunction with other potassium-lowering medications
Sodium zirconium cyclosilicate, Acute hyperkalemia, Acute hyperkalemia managementZS-9, Silicates-therapeutic use, Zirconium-therapeutic use
Chemicals and Drugs | Other Pharmacy and Pharmaceutical Sciences
Brandes, Austin; Thompson, Hannah; and Huiras, Paul, "Evaluating the Effect of Sodium Zirconium Cyclosilicate in Acute Hyperkalemia Management" (2019). Pharmacy Posters. 6.
Poster presented at The American Society of Health-System Pharmacists Midyear Clinical Meeting, December 8-12, 2019; Las Vegas, NV